
Benjamin-Schrank
Feb 28, 2025, 10:42
Benjamin Schrank: Why do tumors evade immune detection, even when phagocytosed?
Benjamin Schrank, Radiation Oncology Resident at MD Anderson Cancer Center, shared a post on X:
“Why do tumors evade immune detection, even when phagocytosed? How can new therapies enhance tumor antigen presentation? Our first paper of 2025 may help answer (some of) this in Nature Cancer
So very thankful to Betty Kim and Nano Wenjiang for their mentorship
Congratulations to all who helped make this project a reality especially Yifan Wang, DaeYong Lee, and Annette Wu.”
Authors: Benjamin R. Schrank et al.
Abin Antony
Adam J. Grippin
Albert C. Koong
Annette Wu
Benjamin R. Schrank
Benjamin Schrank
Betty Kim
Betty Y.S. Kim
cancer
DaeYong Lee
Jared Edwards
Jing Li
JongHoon Ha
Kristin Huntoon
Kyuson Yun
Mengyu Chang
Minjeong Kang
Nano Wenjiang
Nhat Tran
OncoDaily
Oncology
Seong Dong Jeong
Shiyan Dong
Thomas D. Gallup
Wen Jiang
Yifan Ma
Yifan Wang
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 28, 2025, 10:42
Feb 28, 2025, 09:48
Feb 28, 2025, 09:38
Feb 28, 2025, 09:18